Takeda Gets GI Candidate – And Possibly Company – In Altos Deal
This article was originally published in PharmAsia News
Executive Summary
In the latest in a string of deals, Takeda's agreement to acquire global rights to Altos's gastroparesis candidate - and possibly the company itself - gives the Japanese giant another asset in its core gastrointestinal area.